FDA Signals Fresh Scrutiny Of Opioid Painkillers

By Jeff Overley (December 19, 2012, 12:29 PM EST) -- The U.S. Food and Drug Administration said Wednesday it would devote a two-day hearing to the use of opioids in chronic pain, a move that could affect some of the nation's most widely prescribed drugs and that suggests the FDA is eyeing new restrictions on the highly addictive medications....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!